Compared to IMRT alone, the combination of IMRT and MWD treatment for cervical cancer patients can significantly downregulate tumor markers and levels of TGF-β, bEGF, and HMGA1, increase tumor control effectiveness and patient QoL, and improve disease prognosis. This evidence concerns the gene TGFB1 and cervical cancer.